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Recent advancement in diagnostic imaging has made the mortality rate associated with pros-
tate cancer (PCa) to decrease drastically. Given to lower threshold cut-off values for prostate-
specific antigen (PSA) which is the primary augury aside from clinical signs and symptoms for the 
presence of cancer and indication for ultrasound-guided biopsy analysis. Due to its availability, 
low cost, justification and well tolerance of the patient, ultrasound (US) stays to be the golden 
modality for prostate evaluation and real-time biopsy guidance. 
 
While US stays to be in the first line of a diagnostic prediction method for the presence of PCa 
it is mainly used for biopsy guidance on account of its lower sensitivity and specificity towards the 
differential of cancer from other pathologies and relatively high rate of false negative results. 
 
Due to the variable sonographic appearance of the malignancy and its similarity with the non-
malignant conditions, it is always possible only to differentiate cancer from the non-cancerous 
conditions by using biopsy. Moreover, in cases where malignant conditions are apparent together 
with the non-malignant pathologies there will be the superimposition of echo signals making the 
differential diagnosis difficult. 
 
Image processing and texture analysis can improve the diagnostic details obtained from digital 
diagnostic two-dimensional (2D) or three-dimensional (3D) images. We can analyze the image 
texture parameters quantitatively using the specific MaZda software to ascertain different anat-
omy for distinguishing normal from the abnormal tissue structures. 
 
In this thesis work prostate, US images texture parameters are analyzed using MaZda soft-
ware to distinguish the classic texture distribution of PCa. All patients in the study had elevated 
PSA value and biopsy has confirmed the presence of malignancy. 
 
Keywords: ultrasound, prostate cancer, sensitivity, specificity, pixel, voxel, image processing, 
texture, texture analysis, MaZda, region of interest (ROI) 
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1. INTRODUCTION 
Complications related to prostate are most prevalent in men with age beginning from 30 
years. Most men who are diagnosed with prostate pathologies are in their mid or above 
mid ages. The most common disease associated with the gland is benign prostatic hy-
perplasia (BPH) which is the benign enlargement of the prostate tissue with no associ-
ated malignant cell proliferation and angiogenesis, PCa is the cancerous proliferation of 
the cells and there is a possibility of infiltrating to the surrounding structures. prostatitis 
(acute and chronic) is the inflammatory reaction of prostate towards bacterial or viral 
invasion and antibiotics can be prescribed to alleviate the problem, calcifications are the 
presence of smaller stones in the gland and they can be caused secondary to ongoing 
pathologies such as BPH and PCa [1]. 
The major focus of this thesis work is on PCa pathophysiology, routine clinical and radi-
ological diagnostic methods and the most recent advancement in medical image pro-
cessing and image texture analysis using MaZda that improves the diagnostic infor-
mation obtained from the digital diagnostic 2 D or 3D images. 
PCa is the most common malignancy (adenocarcinoma in 95% of cases) in men and the 
second leading cause of mortality in the US [2]. As per the American cancer society 
statistics, 180,890 new cases are observed each year and in 2016 only the death rate 
was recorded at 26,120[1]. 
The etiology of the disease is not known but the epidemiology has a big variation based 
on the difference in age, ethnic class, geographical location, family hereditary history and 
the way of lifestyle. It is predicted that the incidence of the disease will increase in the 
future especially in western and other developed nations due to the higher proportion of 
the aging population. In general, the probability of being diagnosed with PCa throughout 
the person’s lifetime is 11% and 1 in 26 dies from the confirmed malignancy and its 
complications [3]. 
Early detection of PCa is the crucial step for the availability of a wide range of treatment 
options to be chosen, increased patient comfort towards the treatment, better treatment 
response and higher survival rate. Screening programs mainly targeting those who are 
above 50 years of age and with a positive family hereditary history has made the mortality 
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rate drastically low [4]. Blood test to evaluate if there is an elevated level of PSA, a gly-
coprotein secreted by prostate in normal conditions, which does liquefy the seminal fluid 
in order to improve the motility of the sperm and act as a basic buffer to neutralize the 
acidic vaginal and cervical environment, is a precursor to suspect the presence of PCa. 
The major drawback of the screening option using PSA assessment is that it has a higher 
rate of false positive and false negative results. It has been observed that a PSA level 
above 4µg/L has a 37% sensitivity to malignancy and 15% of those who have PSA level 
less than 4ng/L has shown adenocarcinoma during a biopsy. This is because the amount 
of the protein (PSA) secretion may be increased related to other pathologies other than 
PCa and at a normal situation the PSA serum level is increased in direct proportion with 
age, this has made the interpretation ambiguous and the result has to be always com-
pared with the medical history of the patient. PSA evaluation can be combined with Dig-
ital rectal examination (DRE) which enables the clinician to assess the structure of pros-
tate by palpitation in order to affirm if there is any tissue irregularity is also another 
screening option [5, 6]. 
Trans-rectal ultrasound (TRUS) is the major imaging modality that can be used if the 
patient has no any contraindication such as prostatitis, Crohn's disease and no abdom-
inoperineal resection for imaging of prostate to detect PCa. 70% of the adenocarcinoma 
is originating from the peripheral zone (PZ). At normal condition, the PZ has a higher 
echo signal than the CZ and TZ. Any abnormality in echo signal, boundary irregularity, 
the presence of nodular foci and angiogenesis in this zone is a strong indication of ma-
lignant invasion. Most of the time the ultrasonic appearance of PCa is hypoechoic but it 
can vary from hyperechoic mimicking BPH to isoechoic as in prostatitis. Although TRUS 
is the widely accepted diagnostic method it has a low sensitivity and specificity with 50-
60 % accuracy. This is the major reason biopsy using TRUS guidance has to be taken 
and confirmand [6]. 
The lack of sensitivity and specificity is the main limitation in the current diagnostic meth-
ods in use. Increasing the diagnostic information obtained from the medical digital 2D or 
3D images using image texture analysis can increase the diagnostic accuracy and avoid 
unnecessary repeat procedures that will decrease the economic expenses and increase 
patient comfort avoiding invasive procedures. 
MaZda is a software package developed by European COST B11 project, the intention 
of the project was to develop a method for mathematical texture analysis of MRI images. 
The name of the software MaZda emerges from the texture parameter that was primarily 
analyzed (co-occurrence matrix, that is based on statistical distributions of image tex-
tures) which is spelled “Maceierz Zdarzen” in polish language. MaZda gives a free choice 
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to use the whole image or choose a specific region of interest (ROI) to be further ana-
lyzed. The results of the analysis can be presented in the form of image feature distribu-
tion (feature maps) or in the form of a text list of the features (feature vectors) which is 
subjective to choice [7, 8]. 
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2. THEORETICAL BACKGROUND 
2.1 Prostate anatomy 
Prostate belongs to the male accessory reproductive organs, which secretes a basic 
fluid. The organ is composed of both glandular and stromal components adjoined by a 
fibrous capsule with inner smooth muscle and outer collagen layers [9]. 
The name prostate comes from the Greek word “prohistani” meaning to stand in front. 
The prostate got its name from its regional anatomic position, which it stands in front of 
the urinary bladder. The fluid-filled urinary bladder (UB) is used as a diagnostic window 
to measure prostate volume for diagnosis of prostate pathologies using transabdominal 
ultrasound. An abnormal volume might be an indication of disease prognosis such as 
BPH and PCa [10]. 
Regionally prostate is located in the subperitoneal space below the pelvic diaphragm 
bordered by the symphysis pubis anteriorly, rectum posteriorly and the UB superiorly. In 
non-pathologic condition, the gland measures 4 cm in transverse, 3cm in vertical and 
2cm in anteroposterior directions with a total weight of approximately 18g. In a normal 
adult, the gland has a walnut shape with ventral, dorsal and lateral surfaces. While the 
superior broader surface of the prostate (base) is continuous with the apex of the UB the 
inferior narrower surface (apex) rests on the urogenital diaphragm [2, 9, 11]. The lateral 
pelvic wall makes a border with the two inferolateral apical surfaces bilaterally. The pre-
prostatic urethra enters the prostate traversing the base at mid-section and becomes 
prostatic urethra and exit later from the anterior surface close to the apex, while the ejac-
ulatory ducts enter into the gland from the posterior surface of the base and terminate at 
the verumontanum. The posterior aspect of the prostate and seminal vesicles are sepa-
rated from the rectum by the thin layer of connective tissues called the denonvillier’s 
fascia, which is used as a surgical excision border for rectal cancer [12]. Figure 2.1.1 
shows the regional relation of prostate within the pelvic cavity. 
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Figure 2.1.1 Cross-sectional anatomy of male pelvis showing 
the regional relation of the Prostate with the surrounding struc-
tures [13]. 
Initially, the lobar concept of prostate anatomic classification that was based on similarity 
with an animal was widely in use. However, due to lack of distinct lobes in humans, it 
was later replaced by MacNeal zonal division system [12]. Accordingly, the prostate is 
divided into four distinct zones based on histologic, anatomical (structural) and rate of 
pathologic incidences. The central zone (CZ), transition zone (TZ) and the peripheral 
zone (PZ) comprise the glandular section of the prostate (that constitute 70% of the total 
volume of the gland) while the anterior fibromuscular stroma (AFMS) belongs to the mus-
cular component (compose 30 % of the total prostate volume) [9, 11, 14]. 
PZ is the largest of all zonal compartments covering 70% of the prostate glandular tis-
sues. It encompasses the dorsal, apical and inferior section of the prostate. The secre-
tory ducts in this zone are emptied directly to the prostatic urethra in its entire length. 
This is the typical zone for the manifestation of PCa and chronic infections (prostatitis) 
[9]. 
The CZ which is enclosed in between PZ and TZ comprise 25% of the prostate glandular 
tissue mainly forms the base of the prostate. It has a cone shape morphology where the 
apex terminates at the verumontanum (V). The ejaculatory ducts (ED) traverse this sec-
tion to meet the prostatic urethra at the V [9]. This zone is less likely to be infiltrated with 
malignancy and only 1-5% of PCa emanates from this zone [11]. CZ will undergo atrophic 
change associated with aging and hypertrophy of the TZ (BPH) will have a mass effect 
on this zone [12]. The ductal tract from this zone follows the path of the ED to be inserted 
at the V [15, 14]. 
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TZ constitute 5% of the glandular tissues surrounding bilaterally the mid part of the pros-
tatic urethra. This zone is the main susceptible section for BPH with a mass effect (com-
press) on the urethra that will be presented as symptoms related to UB obstruction [9, 
14].The ventral section of the prostate is enclosed by the AFMS that doesn’t have any 
glandular tissue but muscular tissue. The distal section of this zone is important as a 
constriction function to eject secretory products [15]. Figure 2.1.2 shows the glandular and 
stromal area of prostate and their interrelationship. 
 
Figure 2.1.2. Zonal classification of a Prostate. The TZ sur-
rounds the Prostatic urethra bilaterally near the V. CZ is trav-
ersed by the ED. The PZ enclose both the CZ and PZ except 
the anterior surface where AFMS is located [3]. 
The bilateral neurovascular bundles are located in the posterolateral aspect of the gland 
and it regulates the structural development, function, and specialization of the prostate 
cells. This site also affects sexual activity such as penile erections. Any medical man-
agement procedure for prostate treatment has to avoid the occurrence of any complica-
tion on this site [12]. It is also the primary area of interest for contrast and Anastasia 
administration during contrast-enhanced Doppler ultrasound and during TRUS guided 
biopsy extraction. Disease prognosis especially PCa can be evaluated by assessing this 
area for any irregularity and angiogenesis since the lymphatic and the vascular plexus 
are the primary route for adenocarcinomas metastasis [3, 12]. 
Seminal vesicles (SVs) located cephalic to the base of the prostate join the vas deferens 
(VD) bilaterally to form the ED that is inserted to the urethra at the V. It is rare that the 
SVs become the primary site for any of the prostate pathologies but their inspection is 
vital in order to asses if there is advanced PCa [12]. 
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The vascular supply to the prostate may originate from different sources in different indi-
viduals and it is observed that there is a variation in the number of branches between 
the right and left side of the gland. The prostatic artery (PA) may originate from either 
the anterior gluteal–pudendal trunk, obturator artery, internal pudendal artery or inferior 
gluteal artery. The arterial supply to the prostate will branch from one of the origins men-
tioned as a prostate-visceral artery and later re-branch into inferior visceral artery and 
PA to supply the gland. Identifying the correct branching and direction of the PAs is very 
important during prostate artery embolization (PAE) for the treatment of BPH. Correct 
catheterization of PA before PAE will avoid ischemic complications to the surrounding 
organs including the bladder by avoiding unwanted embolization of arteries supplying 
the organs other than the prostate [16]. Figure 2.1.3 illustrates the possible origins of 
vascular supply to prostate in different individuals. 
 
Figure 2.1.3 Possible origin of PA, the internal iliac artery is 
the source of all the possible origins of the PA. The internal pu-
dental artery is the most common origin for PA. The result was 
found by studying 25 (n=25) cadaveric specimens with 
2x25(50) male pelvic side in total and associated percentage 
of samples with the same PA origin [16]. 
2.2 Prostate physiology 
The prostate is composed of 30-50 branching tubules that terminate in secretary alveoli 
and a stroma, which is mainly muscular. Both the glandular and muscular components 
are covered by a fibrous capsule that separates the gland into compartments of lobules. 
The glandular tissue is arranged in the three layers, mucosa, submucosa and upper layer 
from inner to an outer surface. The outer surface is the main surface that contains most 
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of the secretory cells. The prostatic ducts from the inner glandular layer directly open into 
the prostatic urethra and the ducts from the rest of the glandular tissues are attached 
with the prostatic sinus on the ventral aspect of the urethra. The secretory products are 
forced into the urethra by using the involuntary contraction of the FMS [17]. 
The glandular epithelium is composed of secretory cells (SCs), basal cells (BCs), stem 
cells, amplifying cells and neuroendocrine cells. Luminal cells or SCs are the most abun-
dant type of cells. prostate-specific antigen (PSA) and prostate acid phosphate (PAP) 
are the major secretory products of these cells. They are dependent on androgen (cy-
tokeratins 8 and 18 are cell surface androgen receptors) for their function, proliferation, 
and differentiation [17]. 
Stem cells are located close to the basement membrane and they have a capability of 
differentiating to secretory cells. They can undergo both symmetric and asymmetric di-
vision in order to self-renew or specialize to become luminal cells (SCs) of the prostate 
epithelium. Asymmetric cell division of stem cells will result in a production of two daugh-
ter cells one with identical with the parent steam cell to replenish themselves and pro-
genitor cells that will later specialize to intermediate cells, the intermediate cells will again 
differentiate to become SCs and neuroendocrine cells [17]. Figure 2.2.1 illustrates the 
cellular architecture of prostate tissues. 
Figure 2.2.1 The cellular anatomy of prostate epithelium. The stem 
cells have a capability of both self-renewal and differentiate into ei-
ther BCs or SCs. the intermediate cells have the same cell markers 
as the SCs and BCs [18]. 
 
Neuroendocrine cells (NECs) are highly differentiated cell types which are contained all 
over the lumen and some of them (open types) has longer branches that extend to be in 
contact with the lumen and the second types (open) does not have any extension to-
wards the lumen. They are independent of androgen and chromogranin is their cell sur-
face marker. They have a monitoring function on the development, specialization and 
physiologic balance of the glandular function [17]. 
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2.3 Prostate cancer (PCa) 
PCa can either originate from tumors that are derived from the glandular epithelial sec-
tion or from the muscular tissue component. Tumors originating from the secretory com-
ponent of the gland has different structural emergence that will be the base for their 
classification, the majority of them (90%) have an acinar appearance with microacinar, 
atrophic, Pseudohyperplastic and signet ring as their sub-types [19]. Almost 95% of the 
PCa emerges from the glandular epithelial portion of the prostate, with progressive loss 
of the basal cells and in case of malignant invasion; there will be a rapture of the base-
ment membrane. PCa incidence has a variable probability in different zones of the pros-
tate, in 70% of the case the PZ is the origin of the adenocarcinoma, while the CZ and TZ 
have 25% and 5% probability of being infiltrated with the malignancy. Once the elation 
of the basement membrane occurs, there will be a higher possibility of metastasis to the 
surrounding organs such as SV, UB, penial and rectal tissues in less possible incidences 
[20]. Pathological fracture and sclerotic lesions of the bone particular the spinal bones is 
a typical sign of PCa metastasis that can be diagnosed by imaging, metastasis to ab-
dominal and thoracic visceral organs can also occur in very rare conditions [21, 22]. 
Tumors originating from the muscular section of the prostate are very seldom and they 
usually occur with people with hematologic malignancies such as leukemia. Leiomyosar-
coma and solitary fibrous tumors are examples [19]. 
The SCs of the prostate is the primary cellular sites for the manifestation of PCa, malig-
nant glandular neoplasia. The pathogenesis of the carcinoma can be addressed starting 
from the stem cell, which differentiates all the way from a variety of intermediate pre-
cursor stem cells to the final SCs according to the hierarchical or stem cell model of PCa 
prognosis. The cells of the prostate are organized in a basal and laminal layer, while 
those cells of the basal layer contain a cell surface receptor which response to the growth 
factors (GF) produced by the smooth muscle cells of the FM section, only a small amount 
of this cells possess androgen receptor. Those that contain androgen receptor are con-
sidered the stem cells for the development of intermediate amplifying cells and later to 
SCs. When the stem cells are mutated or lost the succeeding intermediate SCs will be 
changed into malignant cells, and each cell type may differentiate in its own path to be 
the source of final PCa that leads to the heterogeneous characteristics of the malignancy 
[23]. Figure 2.3.1 shows normal cellular stratification and malignancy prognosis path-
ways. 
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 Figure 2.3.1 a) Normal cellular anatomy of the prostate epithe-
lium. B) The hierarchical model of tumorigenesis in the prostate 
gland. Steam cells will differentiate to progenitor cells and later de-
differentiate to intermediate cells and finally to SCs. Mutation can 
occur at any stage of cellular differentiation and each cell type in-
volved will take its own course of malignant transformation giving 
rise to the variable appearance of PCa [23]. 
The cause of the transformation from the normal glandular structure to malignant foci is 
not clearly identified. Epigenetic, genetic and oxidative damage due to the response of 
the inflammatory cells secondary to infection is mentioned as a possible underlying factor 
for the prognosis of PCa. There is strong evidence that prostate atrophy secondary to 
inflammation caused by infection is a major factor for the development of PCa. Most of 
the prostate atrophic anomalies are associated with inflammation and most inflamma-
tions will cause intraepithelial atrophy [23, 24]. 
Inflammatory response due to infection will let the inflammatory cells to produce oxygen 
and nitrogen-based ions radicals when they combine with environmental factors such as 
diet they will cause oxidative damage that involves active oxygen and nitrogen species 
(ROS, RNS ) being attached with the genetic material to lead to malignancy on the long 
run. Cells have a checkpoint mechanism to avert the effect of oxidative damage. The 
catalytic mechanism is used by cells to remove this active ion radical, develop a pathway 
to heal the damaged genetic material or in case of advanced DNA damage the cells will 
be forced to undergo controlled suicide. If the cells fail to defend themselves from this 
inflammatory damage, using the methods mentioned carcinogenesis would be initiated. 
Oxidative damage secondary to infection has a strong resemblance with the way cancer 
cells cause damage to the surrounding cellular structures. During oxidative damage to the 
cells, there will be higher expression of immune cells near the infection site, anti- apop-
totic genome (BCl2), a higher expression of KI67 protein, an input for cellular prolifera-
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tion, less expression of cell cycle checkpoints such as p27, increased presence of gluta-
thione-S-transferase p1 (GSTP1) and cyclooxygenase-2 (COX-2). Oxidative damage will 
cause the atrophic change to the SCs and the process is called proliferative inflammatory 
atrophy (PIA) that occurs after successive infections, sudden cellular damage, immune 
complications and lack of oxygen due to vascular anomalies. Expression of GSTP1, 
GSTA1, and COX-2 are the manifestation of PIA. Despite the fact that there is 42.5% 
similarity between the contours of PIA and prostate intraepithelial Neoplasm (PIN) there 
are some non-uniformity to decide whether PIA is the antecedent for the development of 
PIN. That might be due to a low degree of correlation between the two lesions or poor 
structural similarity of the two [23, 25].Figure 3.2.2 microscopic appearance of PIA. 
 
          Figure 2.3.2 Histologic appearance of PIA [23]. 
PIN is a lesion associated with the uncharacteristic nuclear configuration and increased 
proliferation of the SCs with maintained basal membrane. Depending on the level of nu-
clear abnormality, PIN is classified into two types, the low-grade PIN (LGPIN) with a var-
iant appearance from person to person and low specificity for the detection of cancer, 
due to this fact pathologists do not usually report on this type of PIN. The high-grade PIN 
(HGPIN) has a strong sensitivity to cancer detection (22-25%) on biopsy study while the 
low-grade PIN is within the18-20% range. HGPIN is not apparent on imaging or physical 
examinations, only histologic monitoring is the possible method for its diagnosis [23, 26]. 
Figure 2.3.3 shows the microscopic appearance of HGPIN. 
 
Figure 2.3.3 Histologic appearance of HGPIN. The basement membrane 
is shown intact while the tall columnar SCs are transformed into malignant 
cells with the irregularity of the nucleus [23]. 
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The fact which makes the HGPIN as a predecessor to PCa is, in both cases, there is an 
increase in proliferation rate with time. in 70% of specimens studied during biopsy it was 
found to have similar contour, a disappearance of the basal cells and increased rate of 
nuclear abnormality and both have a similar expression of genetic molecules such as α- 
methylacyl-CoAracemase-AMACR)[23].Figure 2.2.4 shows steps of PCa prognosis   
 
Figure 2.3.4 Steps involved in the malignant transformation of normal 
prostate cells with the intermediate steps (PIA and PIN) and the pro-
cesses happening [26]. 
 
The other important factor for the development and carcinogenesis of PCa is androgen. 
Androgen belongs to a group of steroid hormone secreted mainly by testis and adrenal 
gland, and to a small amount by the peripheral organs including squamous cells and 
prostate gland. In a normal male, the function of this hormone is the development and 
specialization of reproductive organs and in a later age, it will initiate the onset and de-
velopment of secondary sex behaviors [27]. 
Outside the intraProstatic environment, androgen is mainly contained as a form of tes-
tosterone. Out of the total volume of circulatory testosterone 44% of it makes a high 
affinity based binding with the sex hormone binding globulin(SHBG), 54% of it is making a 
low affinity based binding with a serum protein albumin. The remaining testosterone (1- 
2%) circulate as unbinding and free. Free testosterone from the circulatory system will 
diffuse passively to the cytoplasm of prostate cells, while the low affinity bound testos-
terone to albumin will make dissociation from it to pass to the intracellular environment 
the same way as the free testosterone. Once inside the cytoplasm testosterone make a 
one direction metabolism with the mediation of the enzyme 5α reductase to form dehy-
drotestestrone(DHT) . DHT will be attached by the intracellular receptor called androgen 
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receptor (AR) that will carry it to the cellular DNA inside the nucleus to attach it with an 
androgen-sensitive element to initiate the transcription of the genome that will trigger the 
proliferation and development of prostatic cells. The further action of DHT ceased by the 
catalytic action of enzymes 3α hydroxyl steroid and 3β hydroxysteroid to convert it to 3α 
androstanediol (3α-diol) and 3β androstanediol (3β androstanediol glucuronide) to be 
eliminated from the cellular environment[27].Figure 2.3.5 shows the physiologic pathway 
of androgen. 
Figure 2.3.5 Steps involved in the formation of testosterone inside 
the testis and adrenal gland and metabolic pathway of androgen 
(DHT) inside the prostate cellular environment leading to the action 
of androgen on prostate cells and its pathway of elimination form in-
traprostatic cellular environment [27]. 
 
When the level of androgen is in a lower amount for instance during androgen replacement 
therapy, non-steroidal hormones such as estradiol, vitamin D and insulin-like growth fac-
tors (IGFs) can act as a ligand to activate the androgenetic effect on the prostate. The 
coactivator proteins such as ARA54, ARA55, ARA70, ARA160, p160, BRCA1, AIB1, and 
CBP boost the action of androgen by increasing the transcriptional efficiency of AR [27]. 
Although there is no direct relation between the level of circulating testosterone and the 
risk of developing PCa, most types of PCa are dependent on the presence of androgen 
for its development and prognosis, androgen deprivation therapy is the most effective 
method for the treatment of advanced tumors with higher initial treatment response. But 
later has a higher recurrence rate and aggressiveness, this is mainly due to a raised level 
of PSA, AR mutation and nonspecific ligands which increase the sensitivity of AR[27, 
28]. 
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In the early stage, the person may not experience any signs or symptoms of PCa, but as 
the disease prognosis is advancing, the patient will be presented with incontinence, the 
urinating blood (hematuria), difficulty or pain while urinating [29]. 
One or more of these signs and symptoms can be seen due to pathological conditions 
of the prostate such as BPH or other conditions arising from the surrounding organs and 
systems. In addition, in case of advanced conditions, the patient may experience back 
pain due to metastasis to the vertebra and can have associated pathological fracture due 
to osteoporosis. 
2.4 Principle of ultrasound imaging  
US is one method of imaging the internal body structures using non-ionizing high- fre-
quency sound waves. The US enables the imaging of static and dynamic structures in 
real time setting [30]. 
Sound is mechanical energy that needs a medium to propagate from one point to an-
other. When the sound wave enacts the particles in the medium, the particles will vibrate 
in their resting position and colliding with the adjacent particles transferring energy, the 
sequential compression and relaxation of particles is responsible for transferring sound 
energy from source to the destination. Depending on the relative direction of energy 
propagation and direction of particulate vibration sound wave is classified as a transverse 
or longitudinal wave. Only Solid mediums support transverse wave propagation [30]. 
Wavelength (λ), frequency (ƒ), amplitude (A), speed(c) and period (T) are major param-
eters used to describe a wave. 
C is dependent on the type of material medium being high in dense bodies than in lose 
medium , in general US propagates with an average speed of 1540m/s in soft tissues[31]. 
Naturally, occurring crystals (quartz, Rochelle salts, and tourmaline) and artificial crystals 
(zirconate titanate (PZT)) are used to produce and receive US. These materials have a 
capability of converting mechanical energy (sound energy) into electrical energy (piezo-
electric effect) and vice versa (reverse piezoelectric effect) [32]. The crystals are con-
tained inside a US probe (transducer), when an electric pulse is applied on the crystals 
they will create a sound pulse that will be directed into the body, then the transducer waits 
for the returning echoes before sending the next pulse. Each pulse has a duration of 1µs 
and created within an interval of 1ms. The crystals spend most of their time (99.9%) 
listening to the echoes than creating the sound waves that is 0.1% of the time. a single 
crystal that is rotated about a fixed axis at a rate of 1000-10,000rpm or a phased array 
of multiple crystals arranged and stimulated in a sequential fashion is used in US probe 
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to create a 2D screen image [30, 33]. 
As the US penetrates through the tissue, some of the energy is attenuated (absorption 
and scattering). Attenuation is dependent on the material property the sound is traversing 
and the frequency of the sound wave. In soft tissues, attenuation is directly proportion to 
the frequency and in liquids; attenuation is directly proportional to the square of the fre-
quency [34]. 
As the sound wave reaches a boundary between two different structures, some of the 
energy is reflected and part of it will be transmitted. If the angle of incidence is greater 
than 60o, the reflected echo will be received by the transducer to create the image. The 
more intensity of reflected sound the brighter the image displayed [30]. 
Acoustic impedance (z) is a measure of the resistance of the medium particle to sound 
propagation. It is a product of the density (ρ) of the medium and velocity (c) of propaga-
tion through it. The amplitude of energy reflected at the interface is dependent on the 
difference of z between the tissues. The higher the difference the higher the amount of 
reflected energy and the brighter the image [35].Figure 2.4.1 shows principle of ultra-
sound operation. 
 
Figure 2.4.1 Creation, propagation, transmission and reflec-
tion of US at different boundaries [31].    
Amplitude or A-mode is the display of the amplitude of the reflected signal with respect 
to time. The interval on the time axis is directly proportional with the depth of the surface 
the signal is emanated. The time it takes for a signal to reach the transducer is given by 
t=2d/c therefore the depth is given d= ct/2[30, 31]. Figure 2.4.2 show A-mode display. 
           Figure 2.4.2 The plot of signal against depth in A- mode operation [31] 
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B-mode is another alternative of displaying the amplitude of the reflected signal as a 
brightness with respect to time (depth). The degree of the brightness is proportional with 
the amplitude of the reflected signal. B-mode image is created by moving around the 
sound pulse at 90o with respect to the direction of the US beam. When this happens at 
frame rate of 20-40 per second, a visual dynamic image can be created [31, 34]. Figure 
2.4.3 shows B-mode operation of US 
 
Figure 2.4.3 B-mode operation of US in stationary underly-
ing structure. RA is the ratio of reflected sound pressure and 
incident sound pressure [31, 35]. 
By mounting a transducer at a fixed position on top of a dynamic underlying structure, it 
is possible to see the movement of structures with respect to time and this is called motion 
(M-mode) mode [31]. Figure 2.4.4 show principle of M-mode operation. 
 
  Figure 2.4.4 Principle of M-mode operation during a mobile un-
derlying structure [31]. 
2.5 Texture analysis  
Image texture is described by the display, form, and arrangement of part of the image. 
Image texture analysis method by using MaZda will lead to obtaining useful information 
about the underlying physical object (biological structures) [36, 37] A digital image is a 
composition of small rectangular blocks(picture elements or pixels) in case of 2D and 
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voxels(volume elements) in case of 3D pictures which are represented by a gray level 
value. The allowed grayscale values a pixel can have is within the range of 0 to 2b-1, 
where b is the number of bits of the image. Texture analysis is attributed to an assessment 
of the pixel gray level values and their interrelationship in the image [37]. 
Multiple steps are involved in MaZda image texture analysis. Image acquisition (2D or 
3D) is the first step. Windows bitmaps and DICOM are the supported formats to be loaded 
in Mazda [36].MaZda has an option to analyze the whole image at once or to choose a 
specific region of interest (ROI). The results will be displayed as feature maps or a text 
list of features vectors and each way has its own purpose [36]. Figure 2.5.1 shows the 
process of image analysis steps in MaZda. 
 
Figure 2.5.1 Steps involved in image texture analysis using 
Mazda [38]. 
 
Statistical, model-based, structural and image transform methods can be used to ana-
lyze the pixel gray level values and their correlation. Each method has an advantage and 
disadvantage over the other but on this thesis, we have used a statistical method of anal-
ysis. 
The statistical method describes the texture features based on the distribution and the 
interrelationship of the pixel gray level values [37]. The main texture parameters evalu-
ated in the statistical method of texture analysis are histogram that is calculated from the 
gray level of the pixels excluding the interrelationship with the rest of the pixels in the 
image. The main features are mean, variance, skewness, kurtosis, and percentiles [37]. 
Simply histogram counts the number of pixels that have the same gray level value and 
display it in the x-y plane where the x-axis shows the gray level value and the Y-axis shows 
the number of pixels with the same gray level values. Figure 2.5.2 histogram display of 
pixel gray level values. 
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Figure 2.5.2 a) An image with the 5x5 pixels having a gray level value 
between 0 to 7,b) depiction of the gray level values of the pixels. C) The 
corresponding histogram representation [37]. 
Co-occurrence matrix (COM) is derived from the gray level values of a pair of pixels that 
means it is a second derivative histogram. Contrast and entropy are the parameters cal-
culated from COM, while contrast describes the gradient of the pixel gray level values, 
entropy asses how the pixel values change within a given distance of the image. The value 
of entropy is higher if there is an abrupt change of gray level values within a given dis-
tance means that it is a measure of randomness or disorder in the image [36, 37]. 
Run length matrix (RLM) is a count of pixels with a given gray level values and length. 
Horizontal, 45o, vertical and 135o are the run-length matrices that are used by MaZda. 
A fraction of the image (amount of pixels that are included in a given run) and short-run 
emphasis (a portion of runs that have short run length) are the main parameters executed 
by RLM [36, 37]. 
Absolute gradient asses the rate of change of pixel gray level values within the image. If 
the gray level values are changing promptly, we have a higher absolute gradient. The 
values may be assigned either positive or negative depending on the route of transition 
from black to white or white to black. Mean and variance are the parameters derived from 
the absolute gradient. Figure 2.5.3 MRI image display of the absolute gradient matrix. 
 
Figure 2.5.3 a)T1 weighted coronal section of the 
brain. b) Absolute gradient image it shows the 
sharpest contrast on the areas where the gray level 
value difference are higher [37]. 
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3. DIAGNOSTIC METHOD FOR PROSTATE DISEASE 
3.1 PSA tasting  
PSA testing has given a new dimension for detection, management, and monitoring of 
PCa. The disease prevalence is increasing since the implementation of PSA screening 
in 1986. The use of PSA testing has enabled the early diagnosis when the disease is 
only localized to the organ that will have a high treatment response and increased prob-
ability of mending the prognosis. The rate of diagnosis at a later advanced stage with re-
gional invasion has declined by 75% since 2003 [21, 39]. 
PSA has approval for PCa detection since1994 by the United States food and drug ad-
ministration (FDA). Even though PSA testing has made a dramatic improvement in the 
overall detection of PCa and decreased mortality rate due to the disease, there are still 
discrepancies among clinicians who question the justification of the method. This is partly 
because PSA enables the detection of early tumors that does not cause any functional 
deformity to the person, and does not certainly need treatment and the associated com-
plication in the urinary, sexual and gastrointestinal (GI) especially rectal mobility after 
any kind of therapeutic procedure followed [39]. 
Both normal prostate tissues and cancerous tissues secrete PSA and release to the sem-
inal fluid to change the semisolid form of semen to motile liquid form and some part goes 
to the circulatory system. In normal condition, only a small amount of PSA is present in 
the circulatory system this is due to the anatomic architecture of the prostate to maintain 
most part of PSA to remain inside the glandular section. Out of the circulatory PSA, only 
around 20% on average is present as free without any binding with other constituents, 
while around 80% of it is present as binding with protease inhibitors (α1- antichymotryp-
sin) and stay as indolent. The PSA level measured is the sum of both bound and free 
serum amounts [39, 40]. 
The variation in the proportion of circulatory PSA spring from the change in the structure 
of the gland secondary to diseases prognosis (PC, BPH or prostatitis) or due to some 
(invasive) procedures such as TRUS guided biopsy, catheterization, DRE and surgery 
near the vicinity of the gland. External factors such as genetic background, age, and 
physical fitness also contribute to the change in the level of PSA. [21, 39]. The non – 
cancerous conditions are the major factors to increase the rate of false-positive results 
during PSA measurement. If a person is on androgen inhibition therapy using finasteride 
the level of serum PSA will dramatically be decreased and the red out should be doubled 
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for considering further steps in order to decrease overdiagnosis and overtreatment [40]. 
The level of circulatory PSA indicates the risk of associated malignancy. In the previous 
read, up to 97% of normal males who are at their 4th decade or above had a PSA level 
of less or equal to 4ng/ml, based on this the lowest level of PSA to undergo biopsy was 
set at 4ng/ml. This value has false positive diagnostic results in 63% of cases and false 
negative results in 9% of cases. PSA level in the range of 4-10ng/ml has a 75 % false 
positive result for the presence of malignancy [39]. 
Although peoples who have a PSA level less than 4ng/ml does not undergo a biopsy to 
confirm the presence of PCa, it is reported that there is a 15% incidence of high-risk 
malignancy in those who have a PSA level between 0.5 -4ng/ml. One way of accommo-
dating these errors might be to lower the threshold value to increase the detection effi-
ciency but in contrary, it will also incline to false positive results and decrease patient 
comfort and waste of resource due to unwanted biopsy and overdiagnosis/overtreatment 
[39]. 
PSA level also varies with age and on average it will increase linearly with age especially 
after the 5th decade. Common values of PSA in different age groups of normal peoples 
has been established. The measured value of PSA from a given person is compared 
with this age-specific normal values in order to increase sensitivity in young male and 
specificity in older men. By doing this overdiagnosis/overtreatment can be decreased and 
unnecessary biopsy can be avoided [39, 40].table 1 shows normal PSA values in differ-
ent age groups. 
                  Table 1 Age-specific PSA threshold values [39]. 
 
This value has shown to miss 40% of the malignancies on average and they are not widely 
accepted as a prior means of diagnosis. In general, PSA testing is not accurate and 
differential diagnosis from the other pathologies conditions, which also increase the level 
of serum PSA, cannot be solely confirmed. PSA can be used to follow up a newly diag-
nosed PCa to assess the grade and risk of the malignancy and after treatment follow up 
to assess the treatment response and the probability of relapse and the need for addi-
tional management to be used[21, 39]. 
In order to make a differential diagnosis between BPH and PCa using PSA, a new method 
called PSA density (PSAD) is used. PSAD accounts the volume of PZ where most of the 
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PCa is common and volume of TZ that is common for BPH manifestation. The measured 
circulatory PSA value is divided over the volume of TZ or PZ measured using TRUS. For 
PCa the minimum values that lead to biopsy analysis are set to be in the range of 0.1- 
0.18ng/ml/cm3. BPH is predicted when the PSAD is between 0.23-0.38ng/ml/cm3. 
PSDA can also predict the grade of the tumor and can be used as a follow-up procedure 
to predict the treatment effectiveness. PSA to volume ration enables both prediction of 
PCa and differentiation from BPH. Higher PSA/volume has a strong association with PCa 
and if the gland is above 40gram and the PSA is in the range of 4-10ng/ml there is 80% 
accuracy for BPH diagnosis than PCa [22, 39]. 
The reason PSAD is not popular is that it is invasive procedure decreasing the patient 
comfort; accurate measuring of the prostate volume may depend on the personnel skill 
and experience and depend on the architecture of the gland. In addition, the economic 
aspect of the procedure is not good [41]. 
The susceptibility of being diagnosed with PCa in the future can be estimated by PSA 
velocity (PSAV). PSAV measures the rate of change of PSA level per time. In those, 
whose PSA level is measured between 4-10ng/ml and if they have PSAV of 
0.75ng/ml/year, there is 79% probability to develop PCa and 90% accurate differential 
from BPH. PSAV is directly proportional with the serum PSA level, PSAV values between 
0.1-0.5ng/ml/year are set to be the value to initiate biopsy study [39]. In order to avoid the 
variation of PSA due to normal physiologic activities and nonmalignant pathologies dur-
ing the measurement period, there should be enough time intervals of measurement be-
fore the biopsy is followed. PSAV is used as a post-treatment assessment method to 
address the treatment response, probability of relapses and aggressiveness of the ma-
lignancy [41].table 2 shows PSA values and PCa risk. 
Table 2 Probability of exposure to cancer based on PSA and percent-
age of free PSA [39]. 
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3.2 Ultrasound imaging  
US is the ideal first-hand diagnostic modality in genitourinary radiology. US is the prime 
choice of radiologists to access the genitourinary pathologies in real time and during an 
interventional procedure for treatment (aspiration), US-guided surgery and extraction of 
biopsy without causing unwanted complications due to normal parenchymal damage and 
associated hemorrhage due to misplaced aspiration or biopsy needle[42] 
Elevated PSA values and abnormal DRE results are the main indications for performing 
TRUS and TRUS guided biopsy for PCa diagnosis. The contraindications for the TRUS 
guided biopsy are mainly sever rectal hemorrhage, abnormal immune reactions, acute 
prostatitis and rectal ablation [43]. 
Grayscale TRUS is the main diagnostic tool for the initial evaluation of prostate with the 
elevated PSA and abnormal DRE or during the presence of sign and symptoms related 
to the UB abnormality. TRUS can depict the anatomic detail of the gland and the sur-
rounding structures well using a high frequency (5-7.5MHz) transducer. We can obtain 
a high-resolution image for evaluating the gland for the presence and local staging of 
PCa, BPH, and infections [44]. 
Accurate volume measurements can be done using TRUS for calculating PSAD that will 
give a clue between PCa and BPH. Transverse (height) and anteroposterior (width) of the 
prostate is measured using axial scans and since bladder obscures the base of the pros-
tate, we cannot see the full length of the gland on axial scans and have to use sagittal 
scans to measure longitudinal dimensions (length). A prolate ellipsoid formula is mainly 
used to calculate volume [11].Figure 3.2.1 normal prostate ultrasound images. 
                 Volume = height × width × length × 0.52(a prolate ellipsoid formula) 
 
Figure 3.2.1 Axial (a) and sagittal (b) TRUS scan of normal prostate for 
measuring volume [3]. 
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Evaluating prostate for PCa using TRUS is mainly assessing if there is any structural 
abnormalities, low echogenic foci, and abnormality of the fibrous capsule (bulging or ir-
regularity).the structural findings are not very conclusive information for accurate diag-
nosis of PCa. TRUS guided biopsy has to be taken from the area of the prostate that is 
mainly susceptible to the malignancy and any suspected area during TRUS for further 
analysis [3] 
TRUS is an important means of directing prostate intervention (biopsy). The indication 
for this procedure is the same as grayscale TRUS. The patient being in decubitus position 
the US probe is inserted inside the rectum to guide an 18G biopsy needle in the region 
of interest. Samples are taken from six sites of the PZ in a symmetric manner (right and 
left apex, right and left mid gland and right and left base). Samples can also be taken 
from any part of the gland if there is suspected PCa echo signal in order to increase the 
sensitivity and limit repeat biopsy request [11]. 
Although TRUS guided biopsy remains to be the routine procedure to detect PCa it has 
its own limitation. Since samples are taken from a specific area of the gland, there is a 
higher probability of missing the malignancy and there is always a possibility of repeat 
biopsy this is in addition to the sampling mistakes that might be dependent on the expe-
rience of the operator. In the first trial, there is a 60% probability of false negative results. 
However, as the number of repeat biopsy is increased the rate of false negative results 
might decrease. This is the main reason that the traditional six core sampling is becoming 
insufficient to make an accurate diagnosis and has to be increased to 10 or 12 cores [11]. 
Since aseptic methods are not used during TRUS, Infection prevention before and after 
biopsy are managed by using antibiotics. Prophylactic antibiotics are generally adminis-
tered before the procedure. Fluoroquinolones with higher tendency to diffuse inside the 
prostate tissue are used to prevent infections after the procedure mainly because of Esch-
erichia coli. A cleansing enema is also used before the procedure in order to remove the 
fecal material to reduce the probability of microbial invasion through the needle path [42, 
43]. 
US-based interventions require choosing the best route for inserting the probe that makes 
the distance between the biopsy needle and the anomaly minimal and avoiding the in-
termediate structures interfering with the sonic window. The biopsy needle has to have a 
shorter travel distance in order to decrease the risk of unwanted structural damage and 
associated hemorrhage that might in Sevier case leads to the secession of the procedure 
and emergency management may follow. The path of the biopsy needle has to be within 
the range of view and the signal from it should not be superimposed with the signal from 
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the prostate tissue or pathologic echo signals [42]. 
Color or power Doppler US can also be used to demonstrate the vascular characteristics 
of the prostate. In non-pathologic conditions, the prostate has a limited Doppler signal 
but if it is infiltrated with malignancy there might be a prominent increase in the micro-
vasculature. The strength of the Doppler signal is directly proportional to the aggressive-
ness (grade) of the tumor [11]. If the conventional TRUS has shown no sign of malignancy 
we can use color/ power Doppler to detect if there increased vascular density and asym-
metry in the vascular distribution [3].Figure 3.2.2 gray scale and Doppler US of prostate.  
 
Figure 3.2.2 a). Normal axial TRUS scan of prostate with no suspected 
area of malignancy). b) Doppler US of the same scan with increased vas-
cular density and asymmetry (arrow). Biopsy has confirmed malignancy 
[3]. 
Doppler/power Doppler increase the sensitivity of PCa detection by up to 10% but it still 
cannot totally replace biopsy since some cancers have shown no vascular signals and 
in the contrary nonmalignant anomalies can be present with increased vasculature 
[3].Figure 3.2.3 Doppler US of prostate 
 
Figure 3.2.3 A 68 year old patient with abnormal PSA value and 
with no clinical signs and symptoms. Axial scan showing multiple 
low echo signal foci (arrow) with increased vascular density resem-
bling PCa. Biopsy has confirmed there is no malignancy [3]. 
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Elastography is one of the recent diagnostic tools to differentiate normal from the abnor-
mal tissue parenchyma by using a physical means (compression) using US transducer 
as a means of applying deformation and measuring the stain (stiffness) of the tissues. 
Different pathologic conditions have a variable strain response and that will be used to 
make a differential diagnosis between cancerous and non-cancerous tissues [45]. 
It enables to discriminate separate tissue structures based on their variation in stiffness 
and this will be represented as color code together with a B-mode display of the same 
tissues. It measures the stiffness using elastogram and the results will be compared with 
the confirmed strain of malignant samples obtained by prostatectomy. The method has 
a very high efficiency of up to 74% to rule out malignancy with a smaller volume of less 
than 1ml and the accuracy can reach 100% in case of tumors with a volume of greater 
than 5ml [46]. 
Elastography has been also used to guide biopsy extraction showing an increased sen-
sitivity than the conventional methods by 7.1%. It has also increased the advantage to 
detect PCa in patients with lower PSA values between 1.25 to 4 ngml-1[47].Figure 3.2.4 
show elastogram of prostate and grayscale TRUS.  
 
Figure 3.2.4 Axial elastogram scan of prostate showing an in-
creased stiffness on the right side of PZ (arrow). Biopsy has con-
firmed grade 7 carcinoma [47]. 
 
Even though the method has an added advantage for diagnosing PCa it is not popular 
due to its drawbacks. The personnel should have a higher competence and experience 
to identify an area where to apply stress (in order to identify a strain response due to 
suspected carcinoma) since it is not possible to see the spot. This will cause a production 
of non-uniform scans making it harder to choose a biopsy site [45]. 
Contrast-enhanced color Doppler US is also used to demonstrate the smaller and larger 
blood vessels of prostate by administering a miniature contrast agents by intravenous (IV) 
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route. It has been observed that contrast enhanced US guided biopsy has a higher sen-
sitivity than the conventional TRUS guided biopsy [48].Figure 3.2.5 show TRUS versus Con-
trast-enhanced color Doppler US of prostate. 
 
Figure 3.2.5 a) A 57-year old axial TRUS with 4.8 ng/ml PSA with normal 
appearance of the prostate, contrast-enhanced US, b) Doppler US of the 
same person with asymmetric vascular distribution with prominent in the 
right side of Prostate [46]. 
 
A more accurate biopsy extraction and better staging of PCa is possible using magnetic 
resonance imaging (MRI), which has a superior capability to show anatomical details. The 
biopsy needle can be placed in a more accurate position by using MRI guidance than 
TRUS alone. It also enables to document the sampling site that can be used as patient 
history in case of repeat biopsy or future treatment. MRI-TRUS fusion technique used the 
combined capability of both modalities to minimize the sampling error associated with 
TRUS-guided biopsy alone [49]. MRI guided biopsy is not without limitations. The use of 
a magnetic field makes the procedure complicated, it needs a method to reduce motion 
artifact and it is much more expensive [49]. Figure 3.2.6 shows the TRUS and MRI 
images of the prostate. 
 
Figure 3.2.6(a) Axial scan of prostate showing a nodular echo 
poor lesion on the left side of PZ with extension to the fibrous cap-
sule (arrow), (b) T2 weighted axial MRI (b) confirms stage T3a 
with capsular extension with no involvement of left SV (arrow) [3]. 
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3.3 Normal ultrasound appearance of Prostate 
TRUS can produce a good diagnostic detail of the prostate by placing the transducer at 
a possible minimal distance from the gland. In non-pathologic condition, the PZ will be 
seen as a smoothly echogenic or hypoechoic structure while the central part of the gland 
(CZ, PZ) can appear either uniformly isoechoic or hyperechogenic area and they may not 
be seen in clear-cut. The echo signal from PZ is variable between younger and older 
people being composite in older people and uniform in younger ones. TZ is enclosing the 
prostatic urethra and seen as echo poor region the same as the AFMS on the anterior 
aspect of the gland. The fibrous capsule makes a hypoechoic boundary between the 
prostate and the surrounding structures [11, 50]. 
Non-pathologic SVs are depicted without asymmetry with a faint-wall and echo poor in-
ternal signal. They can have a length in the range of 2.5 to 3.5cm with a thickness in a 
normal range of 1.1cm to 1.9cm.  VD is seen as a tubular structure with a prominent wall 
than the SV and seen on the superior and more medial aspect than the SVs [50]. 
PZ constitute the largest of the gland volume and this will decrease proportionally with 
aging. The mass effect from the development of BPH in the TZ will make the TZ appear 
as a smaller size. By using the longitudinal section, we can visualize the ED as higher 
echo signal within the central part of the gland. NVB is seen on the posterolateral aspect 
of the gland in both sides with a triangular appearance in the middle of SV and prostate 
with a lower echo signal [47]. Figure 3.3.1normal axial and sagittal scan of prostate. 
 
 
Figure 3.3.1 Axial (a-c) and sagittal(d) TRUS of normal prostate 
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with detailed normal anatomic structures, vas difference, NVB, neu-
rovascular bundle, u, urethra , sv, seminal vesicles, cz central 
zone,pz, peripheral zone,ED, ejaculatory ducts[47] 
3.4 Pathologic finding of Prostate ultrasound 
3.4.1 Prostate cancer (PCa) 
TRUS can rule out PCa accurately in up to 60% of cases with a correct differential diag-
nostic rate of 6%. There is a variable rate of PCa incidence in different zones of the 
prostate, in a majority of cases (70%), the malignancy is apparent on the PZ, in less extent 
(20% of cases) on the CZ and the reaming rate on the TZ. 60-70% of confirmed PCa 
has a low echo signal, with a confined and nodular structure in 30% of cases and in up 
to 50% of cases, it has an irregular and ill-defined pattern. Of the echo poor findings on 
TRUS, only 17-57% are malignancies [47]. In 40% of cases, PCa can have the same echo 
signal as the PZ and only 1% of the malignancies have echogenic appearance [11, 
51].Figure 3.4.1.1 below shows PCa on TRUS. 
 
Figure 3.4.1.1 TRUS scan of 65 year old with a well-defined 
echo poor carcinoma on the left side of PZ (arrow) [50]. 
During metastatic conditions the prostate capsule will be seen as having an irregular edge, 
the ventral aspect of the fat section will be seen as having obliterated contour. SV can 
be seen if they are infiltrated with the carcinoma. TRUS can rule our extracapsular infiltra-
tion specifically in 50-92% of cases and for SV infiltration, it can have a sensitivity in the 
range of 22-60% with 88% accuracy [11]. 
3.4.2 Benign prostatic hyperplasia(BPH) 
BPH is a pathologic condition arising from solely the glandular section of the prostate. It 
mainly involves the TZ and only 5 % of cases involve the periurethral zone. BPH can 
cause most of the time the hypertrophy of the prostate but it can also be apparent without 
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enlargement of the gland. On the US the TZ will be seen enlarged and will be clearly 
discriminated from the rest of the zones [50]. 
Sonographic findings may vary from well-defined nodular structure to diffuse hypertrophy 
of the central gland depending on the pathophysiology involved. Frequently CZ and TZ 
will have a less echo signal than the PZ but the central gland can also have a non- 
uniform echo signal. If BPH causes a mass effect on the rest of the gland we can observe 
the CZ and PZ with reduced size and demarcated from the TZ with an echo poor fat 
capsule, calcifications secondary to the BPH are observed on the wall of the fat capsule 
[11, 52]. 
Rarely BPH can be presented as a multifocal nodule with a variable sonographic signal 
but most of them will have poor echo signal. The US cannot differentiate these nodules 
from PCa but their areal involvement can give an initial prediction of their source [50]. 
Figure shows the most typical sonographic presentation of BPH. 
 
Figure 3.4.2.1 Axial scan of 65 year old with BPH. 
Central part of the gland is separated from the rest 
of the gland by a hypoechoic fat capsule (arrow), hy-
perechoic calcification following the wall of the fat 
capsule are seen (arrow head) [50]. 
3.4.3 Prostatitis  
 
Prostatitis is mostly seen in younger males with acute or chronic inflammation of prostate 
secondary to pathogenic infections [47]. On US acute prostatitis will cause the enlarge-
ment of the prostate with uniform low echo signal because of edema formation. If color 
Doppler there will be increased vascular perfusion but these findings are not totally con-
clusive of the inflammation and the findings have to be compared with the patient clinical 
presentation. In advanced case there will be a well-defined mass with low to non- echo 
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signal, this is due to the formation of abscess [50].Figure shows grayscale TRUS and 
Doppler US of prostate. 
 
Figure 3.4.3.1 (a) Axial scan of gray scale US 
shows a low echo signal mass on the right side of 
prostate, (b) Doppler US of the same person with 
increased vascular density around the mass [50]. 
 
In the case of chronic inflammations, the US findings have a different appearance than 
on acute prostatitis. The echogenicity of the gland will be diffused, hypoechoic rim line 
on the PZ that is most common finding of chronic inflammation, low echoic nodular struc-
tures with a well-defined or diffused wall similar with the appearance of PCa and appear-
ance of the hairline low echoic rim on the outer edges of the gland [50]. Figure shows 
US appearance of prostatitis on gray scale US. 
 
Figure 3.4.3.2 Axial scan of 47-year-old prostate with a 
prominent manifestation of chronic prostatitis (arrow head) 
[50]. 
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4. MATERIAL AND METHODS  
4.1 Images for the analysis  
Multiple prostate US images (axial and sagittal) that were obtained in real clinical proce-
dure were provided by Tampere university hospital in accordance with the hospital rules 
and regulation of confidentiality and purpose for academic use. 
Axial scan of the prostate that shows normal structural detail, normal anatomic dimen-
sions and without abnormal radiologic signal is chosen for the analysis in order to de-
scribe the normal texture features of the gland.  
Random sample that shows multiple well defined hypoechoic nodular structures on the 
PZ were chosen initially and texture analysis was done separately and comparison of 
statistical parameters from different samples that have a similar echo appearance on the 
same zone of the gland (PZ) was done in order to discern if there is a correlation on the 
given parameters. 
Samples that show low echogenic areas outside the PZ or in the CZ were analyzed and 
comparison was done with the parameters of the similar echo structures seen in the PZ. 
Sample scan that has multiple nodular hyperechoic foci was used for the analysis and 
the results were compared with the previous analysis.  
4.2 Analysis procedure  
The analysis procedure proceeded from analyzing the normal texture features (parame-
ters) of Prostate mainly targeting the PZ where the incidence of malignancy is higher. 
The normal texture parameter results were used for comparison purpose with the texture 
parameters obtained from other similar scans from a different patient where the PZ has 
one or more abnormal echo signal. In each case, all four statistical parameters are ana-
lyzed before drawing the conclusion. 
Two US scans with similar echo signal areas on the PZ were separately analyzed and 
the results were compared in order to draw any similarity between the texture features. 
The main objective of this method of analysis was to formulate standard reference tex-
ture features that might be used for comparison purpose for the future similar areas we 
might encounter from a different patient. For this thesis work, we mainly focus on com-
paring hypoechoic areas on the PZ of multiple scans since PCa is mainly apparent as a 
hypoechoic nodular area on the PZ. 
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Next, we have chosen US images which have shown a hypoechoic are on the central 
part of the gland. The results are compared with the similar echo signals that were shown 
on the PZ of the gland. This analysis was intended to draw if there is any similarity be-
tween the hypoechoic areas on the central part of the gland and PZ. Hyper echoic areas 
located on the gland have been analyzed. We have set a variable number of ROI selection 
and the results have beencompared with each other. 
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5. RESULTS 
5.1 Analysing normal texture features of Prostate PZ. 
For this procedure, we have chosen a sonogram (image 100349_0000.dcm) that shows 
a normal dimension and structural detail of the prostate and there is no sonographically 
visible abnormal signal detected. Figure 5.1.1 shows an axial scan of prostate sectioned 
at the mid gland with normal looking echo signal.  
 
Figure 5.1.1   Sonographically, the gland has normal dimension 
(W=41.9mm, H=30.1mm) and structural details. The PZ has a 
uniform echotexture (confirmed from texture analysis), the central 
part of the gland has a normal looking echotexture.  
By choosing a random region of interest (ROI) on the PZ we are going to execute the 
texture parameters and see if the results concede with the sonographic “normal appear-
ance”. For this purpose, we have chosen three standard ROIs on the PZ. Each ROI is 
displayed with a different color and the color of the histogram is the same as the respec-
tive color of ROI. For this particular demonstration, we have set all ROI on the PZ but 
the same procedure can be applied on any section of prostate.  Figure 5.1.2 shows cho-
sen random ROI on the PZ of the prostate.  
 
Figure 5.1.2 ROI selection on the PZ of prostate. The first 
two ROI are set in more symmetric manner near the right and 
left mid PZ and one ROI is set on the left lateral aspect of the 
PZ. 
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In practical situations, it is a good idea to place all the ROIs in a symmetric fashion in 
order to get the result interpretations more accurate. We expect the symmetric ROI to 
have a strong correlation in all types of texture parameters if the PZ is non-pathologic as 
assumed initially. 
Before we proceed with the results of the texture parameters, theoretically if the PZ has 
no pathologic conditions we expect the ROIs to have a same or very similar results, and 
if we have set our ROI in a symmetric manner then we expect even more strong similarity 
between the symmetric ROI than the non-symmetric ROI. 
Age and the clinical presentation should always be in mind before, during and after the 
analysis. Knowing the age is important on this particular analysis; PZ has a uniform 
echotexture in young people than in old people.  If there is ROIs parameter difference 
and if we would have known, the person is relatively young then we can assume that the 
variation is due to abnormal conditions than in old peoples.  
Histogram-based texture parameters have shown a strong correlation on the maximum 
and minimum luminosity of the ROI.  Figure 5.1.3 shows Histogram of the ROIs with 
similar texture luminosity (maximum and minimum). 
 
Figure 5.1.3 Histogram based texture parameters without signifi-
cant variation on the maximal gray level and minimum gray level 
values of the pixels in the respective ROIs.  
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By roughly observing, the histogram charts we can see that there is no major variation 
on the histogram based texture parameters of the chosen three ROI. However, we can 
further analyze the mean, variance and percentile of the histogram based texture param-
eters to confirm our initial guess. Figure 5.1.4 shows the report window for histogram 
based texture parameters. 
 
Figure 5.1.4 Report window for histogram based texture 
parameters (highlighted blue) with a very strong similarity. 
The variation on some of the parameters is due to the dif-
ferent area of ROI selection and can be cross-checked by 
having the same area ROI in all cases. MaZda has an op-
tion for that procedure.  
RLM based texture parameters (horizontal short run and horizontal long 
run). Run length based texture parameters for three ROI have similar re-
sults (highlighted blue). Figure 5.1.5 shows the report window for RLM 
based texture parameters. 
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Figure 5.1.5 Report window for RLM based texture parameters 
(highlighted blue) with a very strong similarity between ROI se-
lected.  
Absolute gradient based texture parameters for the three ROIs. We can see that the 
parameters (highlighted blue) for the three ROI does not have significant variations. Fig-
ure 5.1.6 shows the report window for absolute gradient based texture parameters. 
 
Figure 5.1.6 Report window for gradient based texture parameters 
(highlighted blue) with a very strong similarity between ROIs. 
 
COM-based texture parameters for the three ROIs showed similar results for ROI3 and 
ROI1. There is a variation of contrast on ROI4 compared with the other two. The sym-
metric ROIs (ROI1, ROI3) have shown a strong contrast similarity as expected and the 
lateral ROI has shown relatively significant variation.  That is partly due to its closeness 
37 
 
to the fibrous capsule and the higher echogenicity from the capsule interfere with the 
analysis making the average contrast become higher. And the other factors is the area 
of ROI selection as we can see the lateral ROI has a smaller area than the other ROIs 
means that there is a small number of the pixels in this area giving the mean contrast 
calculation to have a narrow range.  However, all the other COM parameters have a very 
strong similarity.  Figure 5.1.7 shows the report window for COM-based texture param-
eters. 
 
Figure 5.1.7 Report window for COM-based texture parameters with a 
strong similarity of contrast (highlighted blue) between the first two ROIs 
but variation on the third ROI.  All the other parameters have strong sim-
ilarity in all ROIs. 
From these texture parameters, we can assume that the PZ has a uniform (similar) tex-
ture parameters for the selected ROI coinciding with the sonographic appearance. How-
ever, this is not very conclusive and if we want to increase the accuracy, we need to 
increase the number of ROI to include most or all areas of the PZ. By doing that if, we 
found any ROI with abnormal texture parameters from the rest of ROIs that site will be 
the main area of interest for biopsy extraction and further analysis giving a higher diag-
nostic accuracy and avoid repeat biopsy.   
This method can be also used in cases when a patient has abnormal serum PSA value 
and positive clinical presentation but the TRUS has a normal appearance or if there is a 
suspicion of isoechoic or early stage pathologic echotexture on the zone.  
This “normal” texture parameters results can also be used as a reference to compare 
the texture parameters we might get in case of pathological conditions. 
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However, in practice, we might not start by having this kind of extensive analysis with a 
large number of ROIs because it will be time consuming and has a higher probability of 
commuting errors.  
If we analyze a confirmed, normal PZ of prostate from different age groups, we might 
develop mean standard texture parameters that will be used for comparison. We can 
select the whole PZ that we get from new patients as one ROI and compare it with the 
standard and if it has a strong variation from the standard, we might proceed to the de-
tailed analysis in order to detect the abnormal area precisely. Figure 5.1.8 shows whole 
area of PZ as one ROI. 
 
Figure 5.1.8 Setting the whole PZ as one ROI in order to get a 
firsthand information about the condition of the zone by compar-
ing it with the standard texture features developed from the con-
firmed normal PZ.  
If we do not have the standard and we want to save time and avoid the errors, we can 
set the right PZ and left PZ as single symmetric ROIs and see if they have similar tex-
ture features before proceeding. Figure 5.1.9 shows setting of the right side PZ and left 
side PZ as a symmetric ROI. 
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Figure 5.1.9 Symmetric ROI selection of right and left PZ. If they 
show symmetric texture distribution, we can divert the focus of the 
analysis into the other regions of the gland. 
5.2 Texture analysis of hypoechoic areas on the PZ 
For this particular analysis, we have used a random image (image 102905_0000.dcm) 
that showed a well-defined nodular hypoechoic area on the left lateral PZ. Figure 5.2.1 
shows axial scan of prostate. 
 
Figure 5.2.1 Axial mid gland scan with two well-defined nodular hypoechoic ar-
eas on the left PZ. 
The intention of this analysis is to see the texture parameters between the two nodular 
hypoechoic areas. We have set the two nodular areas as a separate ROI using a free 
hand region of interest selection. Figure 5.2.2 shows ROI selection. 
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Figure 5.2.2 Free hand ROI selection, we have used free hand selection 
method in order to include the full area of the nodular structures precisely.  
 
Histogram based texture parameters have showed a strong similarity between the max-
imum and minimum luminosity of the ROIs. Figure 5.2.3 histogram charts of the ROIs. 
 
Figure 5.2.3 Histogram charts showing a very strong similarity between the aver-
age maximum and minimum gray level values of the pixels in the respective ROIs. 
 
We can execute the histogram report window to see the mean, variance and percentile 
parameters. Figure 5.2.4 shows the report window for histogram based texture parame-
ters 
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Figure 5.2.4 Report window for histogram based texture parameters 
(highlighted blue) with a very strong similarity. The significant difference 
in the variance is created due to an unequal area of ROI selection that 
can be checked by setting one RIO on the first nodule and loading the 
same area ROI on the second nodule (selecting the same area of ROI for 
both). 
COM based texture parameter shows an almost same contrast and entropy between the 
ROIs and in all the other parameters. Figure 5.2.5 shows the report window for COM 
based texture parameters. 
 
Figure 5.2.5. Report window for the COM based texture parameters for 
the ROI showing a strong similarity on the contrast of the two ROI (high-
lighted blue). 
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Absolute gradient-based texture parameters (Gr mean and Gr variance) have same re-
sults. Figure 5.2.6 shows report window for absolute gradient-based texture parameters. 
 
Figure 5.2.6 Report window for absolute gradient showing the same pa-
rameters (highlighted blue) for the two ROI nodules. Mean and variance 
is the parameters of the absolute gradient.  
RLM based texture parameters between the two ROIs have a very strong similarity. Fig-
ure 5.2.7 shows the report window for RLM based texture parameters. 
 
Figure 5.2.7 Report window for run-length matrix for the RIO showing no 
significant variations (highlighted blue). 
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The main conclusion we can make is about the underlying pathophysiologic cause of the 
nodules based on the similarity of the texture parameters in all cases. The final echotex-
ture of the pathology observed is the result of the pathophysiologic pathway the disease 
follows. If two conditions have a different pathophysiologic route they will not have the 
same or similar texture parameters in all four cases. They may appear similar on sono-
gram but the texture parameters cannot be the same. 
Therefore based on the similarity of all the statistical texture parameters for the free hand 
chosen two ROI we can assume that the clinical (pathophysiological) source of origin for 
the two hypoechoic areas is the same or similar, this will make the differential diagnosis 
to be narrow and more accurate. These results are based on a limited number of samples 
and I assume then in order to see and calculate how much accurately MaZda can eval-
uate the difference and similarity between two or more sonographically similar areas we 
need to use more samples (ROI) unlike here with only two samples. 
5.3 Analyzing hypoechoic areas on the PZ from different pa-
tients 
On this thesis, we have used two random scans (102858_0000.dcm and 
102905_0000.dcm) that does not show significant hypertrophy (in order to minimize the 
chance of having the echotexture from BPH) of the gland and that have shown well-
defined hypoechoic areas on the PZ and compare the texture parameters. Random ROI 
is chosen in both scans where hypoechoic well-defined areas are present. 
By analyzing the texture parameters of multiple hypoechoic areas on the PZ of prostate 
from multiple scans, we might be able to produce the standard expected texture param-
eters of sonographically similar areas on the same zone of prostate we might encounter 
in the future scans from different patients. This is helpful in a way that if we see a devia-
tion from the standard that will give us a clue about the pathological nature of the struc-
ture, this, in turn, will make the differential diagnosis more close to accuracy. Figure 5.3.1 
shows axial scans of prostate from two different patients. 
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Figure 5.3.1 Axial scan of prostate from different patients. Both 
sonograms shows well defined hypoechoic area on the lateral 
and mid PZ. 
A freehand ROI selection is used in all cases that will give us a more accurate 
inclusion of the area of interest. Figure 5.3.2 freehand ROI selection in both sam-
ples. 
 
Figure 5.3.2 Freehand ROI selection (green area) on the mid-PZ on the 
first scan and left lateral PZ (red area) in the second sonogram. 
Histogram-based texture parameters have shown a strong similarity between the 
ROIs. The average maximum and minimum gray level values of pixels in each 
ROI have a strong similarity.  Figure 5.3.3 shows the histogram based texture 
parameters. 
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Figure 5.3.3 Histogram charts and report window for histogram based tex-
ture parameters with a strong similarity between the pixel gray level values. 
Absolute gradient based texture parameters have strong similarity but there is a strong 
variation on the Grmean value. Grmean variation on the image (102905_0000.dcm) are 
seen on the area close to the fibrous capsule (because ROI was selected close to the 
capsule). It has been checked by using the standard region of interest selection that was 
set by avoiding the closure to the capsule and the results were found to be without sig-
nificant variation (12.68). So we assume that the echogenicity of the fibrous capsule has 
an effect on the results. Figure 5.3.4 shows the report window for absolute gradient 
based texture parameters. 
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Figure 5.3.4 Report window for the absolute gradient based texture parameters 
without significant variations.  
COM shows a significant difference in the contrast of the two ROI is attributed to the 
echogenic nature of the fibrous capsule where ROI is set close by. But the rest of the 
parameters doesn't show significant variation. Figure 5.3.5 shows the report window for 
COM-based parameters. 
 
Figure 5.3.5 Report window for COM parameters (highlighted blue) with similar 
results between the selected ROIs 
RLM texture parameters also show similar results. Figure 5.3.6 shows the report window 
for RLM based texture parameters. 
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Figure 5.3.6 report window for RLM texture parameters without significant variations 
between the ROIs. 
Therefore the two samples of ROI taken from the two different scans have shown a 
strong correlation between the texture parameters. By analyzing texture parameters from 
a multitude of samples we might derive the average texture feature that will be used as 
a standard reference point for the future analysis of structures with similar echotexture. 
5.4 Analyzing hypoechoic areas outside the PZ. 
Our next step is to analyze hypoechoic structures that are located outside the PZ. For 
this purpose, we are going to use a sonogram (with the dimensions of the gland men-
tioned since all the sample scans we got doesn't show the dimension of the gland) that 
has shown a well-defined echo poor area in the central part of the gland and knowing 
the age and clinical presentations would have added additional information on the sus-
picion of the finding. We can also compare the results with the texture parameters we 
have found from hypoechoic areas located on the PZ. the main objective of this analysis 
is to try to discriminate the PCa(mostly hypoechoic nodular appearance ) that is mostly 
shown on the PZ and the BPH that is frequently apparent on the TZ (or central part of 
the gland in general) based on the texture parameters on top of the most peculiar known 
sonographic appearance.   This will give us an added advantage to accurately differen-
tiate the two pathologies. Figure 5.4.1 shows a sagittal scan of the prostate. 
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Figure 5.4.1 Sagittal scan of the prostate. The sonogram shows sig-
nificant hypertrophy of the gland (w,52.3mm, L, 57mm and 
V,57.0cm3), the PZ is seen reduced in thickness (mass effect from 
the central part of the gland might be responsible) and the central 
part of the gland is seen increased in thickness with well-rounded 
isoechoic area extending from the UB apex to the periphery of the 
gland.  
One first-hand comparison method of hypoechoic regions outside the peripheral zone 
and those in the PZ is to set a number of standard ROI on the central part of the gland 
and look if they have a uniform (similar results) because we have found out that those in 
the PZ has similar texture parameter results. We have checked the other scans on this 
idea but we will use only one scan here to show. Figure 5.4.2 shows ROI selection in the 
central part of the gland. 
 
Figure 5.4.2 Standard random ROI selection in the central part 
of the glnad mainly where the hypoechoic hypertrophied area is 
located. 
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Histogram-based texture parameters have shown a strong variation be-
tween all the selected ROIs. Figure 5.4.3 shows the histogram chart and 
the histogram based parameters report window. 
 
Figure 5.4.3 Histogram chart showing a strong variation between 
the pixel gray level values and the report window shows strong 
variations on all histogram based texture parameters (highlighted 
blue) 
 
COM-based texture parameter has also shown a very strong variation in all ROIs. Figure 
5.4.4 shows the report window for COM-based texture parameters. 
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Figure 5.4.4 Report window for COM parameter, the contrast has a very strong var-
iation and all other parameters also show a strong variations between the ROIs. 
There is a similarity on Grmean between the ROI and significant variation on Grvariance 
.Figure 5.4.5 shows the report window for absolute gradient based texture parameters. 
 
Figure 5.4.5 Report window for absolute gradient based texture parameters with a 
variations in all parameters except the GrMean.  
RLM based texture parameters also have showed a strong variations between  all ROIs. 
Figure 5.4.6 shows the report window for RLM. 
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Figure 5.4.6 Report window for RLM with a significant variations of 
parameters(highlighted blue) between th ethree ROIs. 
We have observed that in most of the texture parameters the ROIs chosen outside the 
PZ have significant discrepancies that can give a clue about the underlying pathology. 
When we compare the results we got during our analysis of hypoechoic structures on 
the PZ the results were similar.  all the results are based on the number of sample scans 
provided and we have found that all the ROI(hypoechoic areas) selected outside the PZ 
have a variation on the texture parameters than those found on PZ.   
5.5 Analyzing hyperechoic areas  
For this analysis, we are going to use a sample sonograms which shows well defined 
echogenic area. Image 100418_0000.dcm shows well defined echogenic structure on 
the mid gland. Figure 5.5.1 shows sagittal scan with well-defined echogenic nodules. 
 
Figure 5.5.1 Sagital scan of prostate without significant 
elongation. There are multiple well defined ecogenic foci 
bilaterally and they extend to UB that tells us that the foci 
are located close to the base of Prostate.  
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We used a free hand ROI selection method setting all the nodular structures on the right 
as a single ROI and those seen on the left as another ROI. Figure 5.5.2 shows the setting 
of the ROI. 
 
Figure 6.5.2 Sagital scan of prostate showing freehand ROI 
selection on the right and left aspect of the gland 
Histogram-based texture parameters have shown strong variations between the selected 
ROIs. Figure 5.5.2 shows the histogram charts and report for histogram parameters. 
 
Figure 5.5.2 Histogram charts have strong variations on the 
maximum and minimum luminosity of the pixels in the selected 
ROIs. The histogram based parameters (highlighted blue) 
have strong variations in all cases 
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Absolute gradient based texture parameters (GrMean and GrVariance) have shown sim-
ilar results (0). Figure 6.5.3 shows the report window for absolute gradient based texture 
parameters. 
 
Figure 5.5.3 Report window for absolute gradient based texture parameters show-
ing a strong similarity between parameters (Grmean,Grvariance). 
COM-based texture parameters (contrast and entropy) have shown a strong similarity in 
the contrast of the ROI selected. The randomness of the pixel gray level values is similar 
in both ROIs but the contrast has a variation in regions where nodular structures are not 
located but it was included together as an ROI with the area that includes the significant 
hyperechoic nodules.  Figure 5.5.4 shows the COM report window 
 
Figure 5.5.4 Report window for COM-based texture parameters (high-
lighted blue).  
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RLM based texture parameters have shown a strong similarity between the ROIs. Figure 
5.5.6 shows the report window for RLM. 
 
 
Figure 5.5.5 Report window for RLM parameters (highlighted blue) show-
ing strong similarity. 
In conclusion, we have a similarity of texture parameters in case of RLM and COM-based 
texture parameters. this analysis is affected by the area of selection that involves a non-
hyperechoic area in between the nodules. In order to check the results, we need to select 
each nodule separately as a single ROI in order to avoid an area in between the focis 
and compare it with the results we obtain. 
For demonstration purpose, we have set 2ROIs on the left and 2ROIs on the right side 
of the prostate where the hyperechoic nodules are located. Figure 5.5.6 shows ROIs 
selected on the right and left side. 
 
  Figure 5.5.6 Increased number of ROI selection that only involves hy- 
perechoic areas. 
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Histogram-based texture parameters have shown a strong variations in all parameters 
that agrees with the first method of analysis. We have checked all the other parameters 
and there is no similarity in any of parameters. Figure 5.5.6 shows the histogram charts 
for each ROIs. 
 
Figure 5.5.7 Histogram charts for each ROI. Even though they all look hyperechoic 
the maximum and minimum luminosity has very strong variations. 
We can make the histogram map of the image in order to filter out the foci particularly. 
Figure 5.5.7 shows the histogram map of the image. 
 
Figure 5.5.8 Histogram map of the same scan showing multiple well rounded 
echogenic nodules on both sides of the prostate.  There is no significant echogenic 
structure on the rest of the gland volume. 
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In general, for any type of abnormal echotexture, some parameters showed a strong 
similarity than the other. In order to identify these parameters and use them as a standard 
reference point a large number of samples that are pre-confirmed may need to be eval-
uated in each particular case.  
The variations between the standard and freehand methods of ROI selection have to be 
considered when we compare the results between two or more areas. Superimposed 
ROI selection may give more accurate results and that might as well be used for cross-
checking purpose with the results we get by using a free hand or standard ROI selection. 
We can also use a polygonal method for ROI selection if we precisely have to include 
the full area of interest especially those that have an irregular border. The line thickness 
of the ROI selection has to be considered also when setting an ROI between two areas 
that have a significant difference in echogenicity and during superimposed ROI selection 
or when setting ROI very close to each other that there is a cross-link between the outer 
borders of the ROIs at one or more points. 
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6. DISCUSSION AND CONCLUSION  
The main intention of this thesis work is to investigate in general if we can determine one 
or more peculiar texture parameters for a given pathologic condition and PCa in particu-
lar by using MaZda. We have seen strong texture parameters similarity of hypoechoic 
areas on the PZ of prostate obtained from different patients this in turn might lead us to 
formulating one standard texture parameters that will describe similar echo signal areas 
obtained in the future.  As a conclusion, MaZda seems to be highly sensitive to differen-
tiate the texture features of normal parenchyma and abnormal tissue structures with a 
significant variation. 
We have also shown that we can determine one or more parameter similarity of texture 
features from different scans (different patients) that have a similar echo appearance. 
MaZda has shown to give results which are in accordance with the analysis at the cellular 
level. On previous studies, MaZda has shown it has the capability to differentiate normal 
cellular structures from the abnormal cellular structures with higher certainty [53]. This 
will give us a clue that since our analysis was conducted at the organ level we can reach 
more accurate results by starting our analysis from the cellular level by analysing PCa 
cell images and comparing the results with the organ level analysis outputs.  
During previous studies conducted at organ level using MRI images similar method of 
procedure is conducted, both standard ROI and freehand ROI selection are used [53]. 
Freehand ROI selection is suitable especially when we have an ROI that has an irregular 
shape and ill-defined border than a condition that is well defined and have a regular 
contour. Comparison or cross-checking of results from both standard and freehand ROI 
can be made by using superimposed ROI and polygonal ROI selection if we want to be 
highly certain about the results. 
No texture analysis of prostate ultrasound images have been published this far. Recently, 
Sidhu et al. [54] reported texture parameters of a functional MRI image in order to detect 
TZ tumour. The whole TZ was set as a single ROI and comparison of parameters were 
done by including and excluding an area on the TZ that contains a significant tumour and 
the results were shown a significant variation [54]. For the ROI that contains histologically 
significant area the kurtosis was found to be -0.05 from T1 image, entropy was 5.37 and 
skewness was found to be 0.08 [54]. During our analysis of US PCa images (well defined 
hypoechoic areas on the PZ), the skewness was 1.26, kurtosis was on average 1 and 
entropy was close to 2. The differences arise naturally from the completely different im-
age information when using different imaging Modalities. We have also shown that by 
making a detailed analysis involving the whole region of the gland with a higher number 
of ROI selection it is possible to detect and locate abnormal conditions that we cannot 
be able to discern on US visually whether due to isoechoic nature or early prognosis of 
the pathology. It is also possible to differentiate the most common non-malignant condi-
tions that show similar echo appearance with the PCa based on texture features with a 
significant variation. At this point, we can increase only the diagnostic accuracy of any 
pathologic conditions and determine if a given tissue has been infiltrated by a single or 
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superimposed condition without accurately determining the pathology. By starting to an-
alyse the texture features of a confirmed pathologic condition and formulating a standard 
reference texture features that have a higher mean accuracy we might in the future be 
able to improve the level of diagnosis by applying texture analysis to US images of the 
prostate. 
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